drugset / Trial / NCT04561466
Trial of Befizal® 200 mg for the Treatment of Leber Hereditary Optic Neuropathy
Phase 2/3
Completed
14 enrolled
Necker-Enfants Malades Hospital
CLAIROP · collabEuropean Georges Pompidou Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
Study of the efficiency of Béfizal® 200 mg in 14 adult patients with a LHON that occurred for less than 5 years. Patient must have certain specific mutations
Timeline
- Start
- 2019-03-26
- Primary completion
- 2022-12-09
- Completion
- 2023-03-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Béfizal | Unknown | 600 unknown | — |
Indications
No indication recorded.